Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Feb-24 8:22 PM View:  | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 12-Feb-24 | Sale (Planned) | 2,573 | $11.44 | $29,435.10 | (< 1%) 454.02K to 451.45K | |
| 12-Feb-24 8:21 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 12-Feb-24 | Sale (Planned) | 1,173 | $11.44 | $13,419.10 | (< 1%) 644.45K to 643.28K | |
| 05-Feb-24 7:12 PM View: | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Feb-24 | Sale (Planned) | 8,669 | $11.54 | $100,040.00 | (2%) 462.69K to 454.02K | |
| 05-Feb-24 7:14 PM View: | Paul Andrea Chief Legal Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Feb-24 | Sale | 3,310 | $11.54 | $38,197.40 | (2%) 153.28K to 149.97K | |
| 05-Feb-24 7:13 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Feb-24 | Sale (Planned) | 11,552 | $11.54 | $133,310.00 | (2%) 656.0K to 644.45K | |
| 05-Feb-24 7:15 PM View: | Lackner Mark Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Feb-24 | Sale | 1,585 | $11.54 | $18,290.90 | (< 1%) 197.31K to 195.73K | |
| 05-Feb-24 7:11 PM View: | Blackwell Kimberly Chief Executive Officer Director | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Payment of Exercise | 20,655 | $11.69 | $241,457.00 | (4%) 504.8K to 484.14K | |
| 05-Feb-24 7:14 PM View: | Paul Andrea Chief Legal Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 112,500 | -- | -- | 276% 40.78K to 153.28K | |
| 05-Feb-24 7:13 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 192,500 | -- | -- | 42% 463.5K to 656.0K | |
| 05-Feb-24 7:15 PM View: | Lackner Mark Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 141,000 | -- | -- | 250% 56.31K to 197.31K | |
| 05-Feb-24 7:11 PM View: | Blackwell Kimberly Chief Executive Officer Director | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 250,000 | -- | -- | 98% 254.8K to 504.8K | |
| 05-Feb-24 7:16 PM View: | Hausman Diane Chief Medical Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 337,500 | -- | -- | 849% 39.73K to 377.23K | |
| 05-Feb-24 7:12 PM View: | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 75,000 | -- | -- | 19% 387.69K to 462.69K | |
| 03-Jan-24 8:21 PM View: | Lackner Mark Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Jan-24 | Grant | 40,000 | -- | -- | 245% 16.31K to 56.31K | |
| 21-Dec-23 5:47 PM View: | Bunker Kevin D. Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 20-Dec-23 | Gift | 24,158 | -- | -- | (3%) 874.44K to 850.28K | |
| 13-Nov-23 5:24 PM View: | Blackwell Kimberly Chief Executive Officer Director | Zentalis Pharmaceuticals, I... (ZNTL) | 13-Nov-23 | Private Purchase | 5,000 | $10.29 | $51,448.00 | 2% 249.8K to 254.8K | |
| 13-Nov-23 5:24 PM View: | Johnson David Michael Director | Zentalis Pharmaceuticals, I... (ZNTL) | 10-Nov-23 | Private Purchase | 17,000 | $9.88 | $167,943.00 | 13% 127.39K to 144.39K | |
| 06-Oct-23 7:19 PM View: | Bunker Kevin D. Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Oct-23 | Sale (Planned) | 6,068 | $19.50 | $118,355.00 | (< 1%) 880.51K to 874.44K | |
| 06-Oct-23 7:18 PM View: | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Oct-23 | Sale (Planned) | 5,482 | $19.50 | $106,926.00 | (1%) 393.17K to 387.69K | |
| 06-Oct-23 7:19 PM View: | Brownstein Carrie Chief Medical Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Oct-23 | Sale (Planned) | 10,628 | $19.50 | $207,298.00 | (9%) 116.31K to 105.69K | |
| 13-Sep-23 4:11 PM View: | Skvarka Jan Director | Zentalis Pharmaceuticals, I... (ZNTL) | 11-Sep-23 | Sale (Planned) | 5,000 | $25.05 | $125,238.00 | (9%) 52.97K to 47.97K | |
| 20-Jun-23 4:30 PM View: | Matrix Capital Management C... 10% Owner | Zentalis Pharmaceuticals, I... (ZNTL) | 20-Jun-23 | Private Purchase | 4,760,000 | $22.66 | $107,862,000.00 | 52% 9.2M to 13.96M | |
| 31-May-23 9:10 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 31-May-23 | Sale (Planned) | 27,768 | $26.27 | $729,506.00 | (6%) 491.27K to 463.5K | |
| 31-May-23 9:09 PM View: | Bunker Kevin D. Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 26-May-23 | Sale (Planned) | 80,000 | $30.02 | $2,401,250.00 | (8%) 960.51K to 880.51K | |
| 10-May-23 7:13 AM View: | Hausman Diane Director | Zentalis Pharmaceuticals, I... (ZNTL) | 08-May-23 | Grant | 39,732 | -- | -- | 100% 0 to 39.73K | |
| 02-Mar-23 4:30 PM View: | Roth Iris Chief Operating Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Mar-23 | Grant | 52,500 | -- | -- | 100% 0 to 52.5K | |
| 14-Feb-23 7:10 PM View: | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 14-Feb-23 | Sale (Planned) | 5,227 | $19.98 | $104,411.00 | (1%) 397.27K to 392.05K | |
| 14-Feb-23 7:09 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 14-Feb-23 | Sale (Planned) | 8,501 | $19.96 | $169,706.00 | (2%) 499.77K to 491.27K | |
| 14-Feb-23 7:07 PM View: | Bunker Kevin D. Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 14-Feb-23 | Sale (Planned) | 6,500 | $19.98 | $129,873.00 | (< 1%) 967.01K to 960.51K | |
| 14-Feb-23 7:09 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 13-Feb-23 | Sale (Planned) | 3,332 | $20.42 | $68,054.10 | (< 1%) 503.1K to 499.77K | |
| 14-Feb-23 7:07 PM View: | Bunker Kevin D. Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 13-Feb-23 | Sale (Planned) | 3,807 | $20.42 | $77,755.70 | (< 1%) 970.81K to 967.01K | |
| 14-Feb-23 7:10 PM View: | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 13-Feb-23 | Sale (Planned) | 2,624 | $20.42 | $53,593.60 | (< 1%) 399.9K to 397.27K | |
| 06-Feb-23 7:36 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 06-Feb-23 | Sale (Planned) | 10,000 | $22.27 | $222,678.00 | (2%) 513.1K to 503.1K | |
| 01-Feb-23 7:08 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 161,092 | -- | -- | 46% 352.01K to 513.1K | |
| 01-Feb-23 7:08 PM View: | Blackwell Kimberly Chief Executive Officer Director | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 244,800 | -- | -- | 4896% 5.0K to 249.8K | |
| 01-Feb-23 7:06 PM View: | Paul Andrea General Counsel | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 40,783 | -- | -- | 100% 0 to 40.78K | |
| 01-Feb-23 7:07 PM View: | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 101,957 | -- | -- | 34% 297.94K to 399.9K | |
| 01-Feb-23 7:06 PM View: | Brownstein Carrie Chief Medical Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 16,313 | -- | -- | 16% 100.0K to 116.31K | |
| 01-Feb-23 7:09 PM View: | Bunker Kevin D. Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 91,354 | -- | -- | 10% 879.46K to 970.81K | |
| 18-Jan-23 5:15 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 17-Jan-23 | Sale (Planned) | 10,000 | $24.15 | $241,515.00 | (3%) 362.01K to 352.01K | |
| 05-Jan-23 7:16 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Jan-23 | Sale (Planned) | 10,000 | $21.02 | $210,228.00 | (3%) 372.01K to 362.01K | |
| 15-Nov-22 7:50 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 15-Nov-22 | Sale (Planned) | 12,500 | $22.77 | $284,683.00 | (3%) 384.51K to 372.01K | |
| 01-Feb-23 7:09 PM View: | Bunker Kevin D. Chief Scientific Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 09-Nov-22 | Gift | 30,000 | -- | -- | (3%) 909.46K to 879.46K | |
| 08-Nov-22 8:38 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 08-Nov-22 | Sale (Planned) | 12,374 | $23.56 | $291,543.00 | (3%) 396.88K to 384.51K | |
| 08-Nov-22 8:38 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Nov-22 | Sale (Planned) | 12,500 | $23.67 | $295,860.00 | (3%) 409.38K to 396.88K | |
| 17-Oct-22 9:02 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 17-Oct-22 | Sale (Planned) | 12,500 | $23.51 | $293,879.00 | (3%) 421.88K to 409.38K | |
| 07-Oct-22 4:40 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 06-Oct-22 | Sale (Planned) | 10,000 | $22.62 | $226,180.00 | (2%) 431.88K to 421.88K | |
| 07-Oct-22 4:40 PM View: | Gallagher Cam President Director | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Oct-22 | Sale (Planned) | 12,500 | $22.32 | $279,006.00 | (3%) 444.38K to 431.88K | |
| 03-Oct-22 6:42 PM View: | Epperly Melissa B, Chief Financial Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 03-Oct-22 | Grant | 50,000 | -- | -- | 20% 247.54K to 297.54K | |
| 03-Oct-22 6:37 PM View: | Brownstein Carrie Chief Medical Officer | Zentalis Pharmaceuticals, I... (ZNTL) | 03-Oct-22 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K |
